CDK19 Polyclonal Antibody

This gene encodes a protein that is one of the components of the Mediator co-activator complex. The Mediator complex is a multi-protein complex required for transcriptional activation by DNA binding transcription factors of genes transcribed by RNA polymerase II. The protein encoded by this gene is similar to cyclin-dependent kinase 8 which can also be a component of the Mediator complex. Alternative splicing results in multiple transcript variants encoding distinct isoforms.

The CDK19 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of CDK19 protein expression in various biological samples. This antibody has been meticulously developed using advanced immunization techniques, ensuring its exceptional sensitivity and specificity.

CDK19, also known as cyclin-dependent kinase 19, is a crucial regulator of cell cycle progression and transcriptional regulation. It plays a pivotal role in the control of gene expression and is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. Dysregulation of CDK19 has been implicated in the development and progression of numerous diseases, making it an attractive target for therapeutic interventions.

The CDK19 Polyclonal Antibody exhibits outstanding performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes endogenous levels of CDK19 protein, enabling accurate quantification and localization studies. With its high affinity and low background, this antibody ensures reliable and reproducible results, facilitating comprehensive investigations into the functional role of CDK19 in diverse biological contexts.

This antibody has been rigorously validated using various experimental approaches, guaranteeing its exceptional quality and reliability. It is produced in compliance with stringent quality control standards, ensuring batch-to-batch consistency and reproducibility. Additionally, it has been extensively tested for cross-reactivity with related proteins, ensuring its specificity for CDK19.

The CDK19 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for multiple experiments without compromising its performance. Its long shelf life and stability ensure consistent results over an extended period, making it an ideal choice for long-term studies.

In summary, the CDK19 Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of CDK19 protein expression. Its exceptional sensitivity, specificity, and versatility make it an invaluable asset for researchers investigating the functional role of CDK19 in various biological processes and disease states.